Control of the vascular endothelial growth factor internal ribosome entry site (IRES) activity and translation initiation by alternatively spliced coding sequences

被引:50
作者
Bornes, S [1 ]
Boulard, M [1 ]
Hieblot, C [1 ]
Zanibellato, C [1 ]
Iacovoni, JS [1 ]
Prats, H [1 ]
Touriol, C [1 ]
机构
[1] CHU Rangueil, Inst Federatif Rech Louis Bugnard, INSERM, U589, F-31403 Toulouse 04, France
关键词
D O I
10.1074/jbc.M308410200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The vascular endothelial growth factor-A ( VEGF) gene locus contains eight exons that span 14 kb. Alternative splicing generates multiple, different mRNAs that in turn translate into at least five protein isoforms. While the canonical AUG start codon is located at position 1039 in exon 1, there also exists an upstream, in-frame CUG initiation codon that drives expression of L-VEGF, containing an additional 180 amino acids. Two separate internal ribosome entry sites (IRES) regulate the activity of each initiation codon. Thus the 5'-UTR of VEGF, which comprises the majority of exon 1, consists of IRES B, the CUG, IRES A, and the AUG, from 5' to 3'. Previously, it has been shown that IRES B regulates initiation at the CUG and IRES A regulates AUG usage. In this study, we have found evidence that the exon content of the VEGF mRNA, determined through alternative splicing, controls IRES A activity. While the CUG is most efficient at initiating translation, transcripts that lack both exons 6 and 7 and therefore contain an exon 5/8 junction lack AUG-initiated translation. The process of splicing is not responsible for this start codon selection since transfection of genomic and cDNA VEGF sequences give the same expression pattern. We hypothesize that long range tertiary interactions in the VEGF mRNA regulate IRES activity and thus control start codon selection. This is the first report describing the influence of alternatively spliced coding sequences on codon selection by modulating IRES activity.
引用
收藏
页码:18717 / 18726
页数:10
相关论文
共 53 条
  • [1] IDENTIFICATION OF A SPECIFIC PATTERN OF VASCULAR ENDOTHELIAL GROWTH-FACTOR MESSENGER-RNA EXPRESSION IN HUMAN PLACENTA AND CULTURED PLACENTAL FIBROBLASTS
    ANTHONY, FW
    WHEELER, T
    ELCOCK, CL
    PICKETT, M
    THOMAS, EJ
    [J]. PLACENTA, 1994, 15 (05) : 557 - 561
  • [2] Arnaud E, 1999, MOL CELL BIOL, V19, P505
  • [3] A single internal ribosome entry site containing a G quartet RNA structure drives fibroblast growth factor 2 gene expression at four alternative translation initiation codons
    Bonnal, S
    Schaeffer, C
    Créancier, L
    Clamens, S
    Moine, H
    Prats, AC
    Vagner, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (41) : 39330 - 39336
  • [4] BRUCCOLERI RE, 1988, COMPUT APPL BIOSCI, V4, P167
  • [5] Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
    Carmeliet, P
    Ng, YS
    Nuyens, D
    Theilmeier, G
    Brusselmans, K
    Cornelissen, I
    Ehler, E
    Kakkar, VV
    Stalmans, I
    Mattot, V
    Perriard, JC
    Dewerchin, M
    Flameng, W
    Nagy, A
    Lupu, F
    Moons, L
    Collen, D
    D'Amore, PA
    Shima, DT
    [J]. NATURE MEDICINE, 1999, 5 (05) : 495 - 502
  • [6] Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability
    Claffey, KP
    Shih, SC
    Mullen, A
    Dziennis, S
    Cusick, JL
    Abrams, KR
    Lee, SW
    Detmar, M
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (02) : 469 - 481
  • [7] Hypoxia regulates the expression of vascular permeability factor vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin
    Detmar, M
    Brown, LF
    Berse, B
    Jackman, RW
    Elicker, BM
    Dvorak, HF
    Claffey, KP
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (03) : 263 - 268
  • [8] Messenger-RNA-binding proteins and the messages they carry
    Dreyfuss, G
    Kim, VN
    Kataoka, N
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (03) : 195 - 205
  • [9] Role of vascular endothelial growth factor in Physiologic and Pathologic angiogenesis: Therapeutic implications
    Ferrara, N
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (06) : 10 - 14
  • [10] Molecular and biological properties of vascular endothelial growth factor
    Ferrara, N
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (07): : 527 - 543